SYMPATHOMIMETICS Flashcards

1
Q

 Constitute a group of drugs used for

  • Cardiovascular
  • Respiratory
  • Other conditions
A

Adrenomimetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Adrenomimetics
Subdivided into:
 Mode of action

A

Direct-acting

 Indirect-acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Adrenomimetics
Subdivided into:
 Spectrum of action

A

 Alpha
 Beta
 Dopamine receptor affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A. MODE OF ACTION

 Bind to and activate the adrenoceptors
 Result to sympathetic stimulation

A

DIRECT-ACTING SYMPATHOMIMETICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

A. MODE OF ACTION

 Displacement of stored cathecolamines in
the synapse
 Tyramine, amphetamine

A

INDIRECT-ACTING SYMPATHOMIMETICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

A. MODE OF ACTION

 Inhibit the reuptake of cathecolamines by
nerve terminals
 Cocaine, tricyclic antidepressants

A

INDIRECT-ACTING SYMPATHOMIMETICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

 Present in the mitochondria in the adrenergic nerve endings
 Inactivates portion of dopamine and norepinephrine in the cytoplasm

A

MONOAMINE OXIDASE (MAO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

 May increase the stores of these transmitters and other amines in
the nerve endings

A

MONOAMINE OXIDASE INHIBITORS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

subgroups of alpha

A

alpha 1

alpha 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

subgroups of beta

A

beta 1
beta 2
beta 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

 Single prototype with effects at all receptors
 Alpha1 and alpha2
 Beta1,beta2 and beta3

A

EPINEPHRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

 Separate prototype

 Alpha

A

PHENYLEPHRINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
 Separate prototype
 Beta
 Synthetic cathecolamine
 Similar to the endogenous transmitters
 Not readily taken up into the nerve ending
A

ISOPROTERENOL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

B. SPECTRUM OF ACTION

 Constitute a third class of adrenoceptors
 Drugs mentioned have little effect on
dopamine
 May act as a potent dopamine receptor
agonist itself
A

DOPAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

 Epinephrine, norepinephrine, and dopamine
 Endogenous adrenoceptor agonists
Rapidly metabolized by COMT and MAO
 Inactive when given by the oral route
 Short duration of action
 When given IV, they do not enter the CNS
in significant amounts

A

CATHECOLAMINES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
 Not a cathecolamine
 Resistant to MAO
 Resistant to COMT
 Orally active
 Enter the CNS
 Longer effects
A

AMPHETAMINES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

 Presence of OH groups at carbons 3 and 4
 Degraded by cathecol-o-methyl transferase
(COMT)

A

PHENYLETHYLAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

PHENYLETHYLAMINE

 Removal of OH will:

A

 Make it resistant to COMT
 Prolong the duration of action
 Increase bioavailability
 Increase the ability to penetrate the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

 Alter the alpha carbon, add CH3
Phenylisopropylamine
Ephedrine, amphetamine

A

PHENYLETHYLAMINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

 Alter the beta carbon, add OH
Direct-acting
Important in the storage of cathecolamines

A

PHENYLETHYLAMINE

21
Q

 G-protein coupled
 Need a 2nd messenger to induce
sympathetic effect

A

ADRENOCEPTORS

22
Q
 Epinephrine > NE > isoproterenol
 Alpha1
 Increase in phosphatidyl inositol (IP3)
 Release of calcium
 Alpha2
A

ALPHA RECEPTOR ACTIVATION

23
Q

 Receptors found in renal vasculature, brain

A

DOPAMINE RECEPTOR ACTIVATION

24
Q

beta1 = beta2

A

DOBUTAMINE

ISOPROTERENOL

25
beta2 > beta1
TERBUTALINE
26
ADRENOCEPTORS ALPHA SELECTIVE alpha1 > alpha2 alpha1 activation
 PHENYLEPHRINE
27
ADRENOCEPTORS ALPHA SELECTIVE alpha2 > alpha1 alpha2 activation
 CLONIDINE
28
``` ADRENOCEPTORS MIXED (activates both alpha and beta) alpha1 = alpha2 beta1 > beta2  EPINEPHRINE alpha1 = alpha2 beta1 = beta2 ```
 NE
29
ADRENOCEPTORS MIXED (activates both alpha and beta) ``` alpha1 = alpha2 beta1 = beta2 ```
 EPINEPHRINE
30
CLINICAL USES A. ANAPHYLAXIS ```  Drug of choice for the immediate treatment of anaphylactic shock  Rapid acting  Pressor agent  Used for cardiac arrest ```
EPINEPHRINE
31
B. CNS  Narcolepsy  Attention deficit disorder  With appropriate control, weight reduction
PHENYLISOPROPYLAMINES | AMPHETAMINES
32
CLINICAL USES C. EYE  Used topically to produce mydriasis  Used to reduce conjunctival itching and congestion caused by irritation and allergy
PHENYLEPHRINE
33
D. BRONCHI  Drugs of choice in the treatment of acute asthmatic attacks
TERBUTALINE, ALBUTEROL, METAPROTERENOL
34
CLINICAL USES D. BRONCHI  Long-acting  Recommended for prophylaxis
SALMETEROL
35
CLINICAL USES F. GUT ```  Long-acting oral sympathomimetic used to improve urinary incontinence in children and the elderly with enuresis  Mediated by the alpha receptors in the trigone of the bladder ```
EPHEDRINE
36
CATHECOLAMINES  Pressor agent  Cardiac arrest  Anaphylactic shock
EPINEPHRINE
37
CATHECOLAMINES  Pressor agent ISOPROTERENOL  Cardiogenic shock
NOREPINEPHRINE
38
CATHECOLAMINES  Cardiogenic shock
ISOPROTERENOL
39
CATHECOLAMINES  Congestive heart failure  Inotropic effect
DOBUTAMINE
40
CATHECOLAMINES  Inotropic effect  Lower doses cause renal vasodilation  Higher doses cause vasoconstriction
DOPAMINE
41
NON-CATHECOLAMINES  Pressor agent  Mydriatic  Decongestant
PHENYLEPHRINE
42
NON-CATHECOLAMINES  Pressor agent  IV form only
METHOXAMINE
43
NON-CATHECOLAMINES  Pressor agent  Orthostatic hypotension
MIDODRINE
44
NON-CATHECOLAMINES  OXYMETAZOLINE, XYLOMETAZOLINE  Topical decongestants
DRIXINE
45
NON-CATHECOLAMINES  Bronchial asthma
TERBUTALINE
46
NON-CATHECOLAMINES  Inhibits premature labor
RITODRINE
47
NON-CATHECOLAMINES  Local vasoconstrictive  Anesthetic effect
COCAINE
48
NON-CATHECOLAMINES  Derivative of tyrosine  Increase BP  Found in cheese and wine
TYRAMINE